InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SHR | Ann: Suspension from Quotation and Removal from Official List | 28/10/15 | 0 | 262 | |||
|
|||||||
SHR | Ann: Letter to Shareholders | 23/10/15 | 0 | 302 | |||
|
|||||||
SHR | Ann: Full Year Statutory Accounts and notice of AGM | 25/09/15 | 0 | 225 | |||
|
|||||||
SHR | Ann: Notice of Annual General Meeting/Proxy Form | 21/09/15 | 0 | 231 | |||
|
|||||||
SHR | Ann: Preliminary Final Report | 31/08/15 | 0 | 237 | |||
|
|||||||
SHR | Ann: Letter to Shareholders | 28/07/15 | 0 | 235 | |||
|
|||||||
SHR | Ann: CLOSE OF TAKEOVER BID REPORT | 22/07/15 | 0 | 237 | |||
|
|||||||
SHR | Ann: Change in substantial holding | 29/05/15 | 0 | 195 | |||
|
See All Discussions